Verfürth Martina
Escuela Internacional de Doctorado UCAM (EIDUCAM) [International Doctoral School], UCAM Universidad Católica San Antonio de Murcia, Guadalupe de Maciascoque, Murcia, Spain.
FOM Hochschule für Oekonomie and Management Essen, Essen, Germany.
Telemed Rep. 2021 Jan 8;2(1):6-13. doi: 10.1089/tmr.2020.0012. eCollection 2021.
Diabetes mellitus (DM) as a chronic disease is a great medical, organizational, and financial burden on the German healthcare system, and it has risen in epidemiological importance. To ensure healthcare against the background of rising prevalence rates and to reduce costs, it makes sense to supplement treatment of diabetes patients with telemedical services.
The aim was to evaluate telemonitoring services for DM patients in Germany and the political/legal environment.
A narrative review was conducted to provide a comprehensive and critical analysis of the current knowledge on interactive telemonitoring offerings and influencing factors. A total of 19 publications were considered as relevant in the screening process, and were included in the content analysis.
The results can be differentiated in terms of political/legal requirements, needs, and supply-related aspects. Only four studies focused on the individual care aspects of telemedical care of DM patients.
Telemonitoring measures for chronic diseases in general and for DM in particular have hardly been implemented in Germany so far. Based on the deficiencies and research gaps described earlier, some recommendations can be made. There is a need to set up structure for more interactivity, to expand technical infrastructure, and to close legal gaps. More research focusing on clinical effectiveness is necessary.
糖尿病作为一种慢性病，给德国医疗体系带来了巨大的医疗、组织和经济负担，其流行病学重要性日益上升。为了在患病率不断上升的背景下确保医疗保健并降低成本，用远程医疗服务补充糖尿病患者的治疗是有意义的。
旨在评估德国针对糖尿病患者的远程监测服务以及政治/法律环境。
进行了一项叙述性综述，以对当前关于交互式远程监测服务及影响因素的知识进行全面且批判性的分析。在筛选过程中，共有19篇出版物被视为相关，并纳入了内容分析。
结果可在政治/法律要求、需求以及供应相关方面进行区分。仅有四项研究关注糖尿病患者远程医疗的个体护理方面。
到目前为止，德国总体上针对慢性病尤其是糖尿病的远程监测措施几乎尚未实施。基于前文所述的不足和研究空白，可提出一些建议。需要建立更具交互性的结构，扩展技术基础设施，并填补法律空白。有必要开展更多关注临床有效性的研究。
